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On validation of multibody
musculoskeletal models
Morten Enemark Lund1, Mark de Zee2, Michael Skipper Andersen1
and John Rasmussen1
Abstract
We review the opportunities to validate multibody musculoskeletal models in view of the current transition of musculos-
keletal modelling from a research topic to a practical simulation tool in product design, healthcare and other important
applications. This transition creates a new need for justification that the models are adequate representations of the sys-
tems they simulate. The need for a consistent terminology and established standards is identified and knowledge from
fields with a more progressed state-of-the-art in verification and validation is introduced. A number of practical steps for
improvement of the validation of multibody musculoskeletal models are pointed out and directions for future research
in the field are proposed. It is hoped that a more structured approach to model validation can help to improve the cred-
ibility of musculoskeletal models.
Keywords
Musculoskeletal modelling, validation
Date received: 25 April 2011; accepted: 9 November 2011
Introduction
Multibody musculoskeletal simulation and model
based estimation of muscle forces is gaining a central
role in decision-making processes within product
design1–3 and orthopaedics.4,5 This development neces-
sitates a justified confidence that the models are ade-
quate representations of the systems they simulate, and
it raises the question of how multibody musculoskeletal
models can be critically evaluated. Which tests are nec-
essary to clarify the assumptions, limitations and uncer-
tainties of the model simulation and how can the
results of such tests be assessed? This is the central
question of the present work, and we shall review liter-
ature from the biomechanics field and from entirely dif-
ferent fields that also rely on the accuracy of models
and have progressed further in their insights on the
topic.
Computer simulations and models of the human
musculoskeletal system have evolved over the past
decades. Development of multibody musculoskeletal
modelling has been driven not only by advances in sci-
entific research,6 but also by the advent of commercial
musculoskeletal modelling systems. System develop-
ments such as AnyBody,7 Lifemodeler,8 SIMM9 and
OpenSIM10 have recently made musculoskeletal models
available to science and industry.
The use of computational engineering for practical
applications adapted to the individual patient holds
significant promise and enormous challenges.11 Indi-
vidually targeted medical care was recently declared by
the National Academy of Engineering to be one of the
major challenges for engineering in the 21st century.12
The expectations of what can be achieved in healthcare
with the help of computational models continue to
grow; fuelled by the increasing speed and capabilities of
computer systems and by the impact computer simula-
tions have had in traditional areas of engineering.
Recent studies have shown the potential of muscu-
loskeletal simulation tools to help clinicians answer
questions or simulate quantities, which were other-
wise impractical or impossible to obtain experimen-
tally.13,14 Output from patient-specific musculoskeletal
simulations may, for instance, determine the strategy
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for a surgical procedure or directly influence diagnos-
tics and decisions on treatment.15–18 Simulation results
can also determine ergonomic product design or be
used for design optimization of orthopaedic implants
and orthoses.1,4,5
A consequence of the transition from science to clin-
ical applications is that the results of musculoskeletal
simulations attain a direct influence on applications
and processes where mistakes and misjudgements are
potentially critical. Diagnostics and surgical planning
are obvious examples where consequences for the
patient are immediate, but use of musculoskeletal simu-
lations in product design may also have serious conse-
quences, albeit typically on a longer time scale.
Computer-aided engineering
Computer-aided engineering (CAE) has conquered
nearly every aspect of traditional science and engineer-
ing. Today, it is inconceivable to design a car, build a
bridge or create an advanced electrical circuit without
the use of computational models. Simulation of muscu-
loskeletal systems can be interpreted as yet another
field for CAE, and it may be valuable to consider the
development of musculoskeletal simulation in light of
the evolutions of related CAE fields.
The argument for the practical use of a computa-
tional model is the opportunity to acquire data or
knowledge that is difficult to obtain experimentally.
This means that the computational model will reach its
full potential only when it is considered reliable enough
not to require experimental evidence of the validity of
each new result. In other words, the model and under-
lying methods must have been sufficiently proven or
evaluated in a general sense to provide confidence in
individual results.
The history of CAE contains many examples of
application fields that have evolved from scientific
developments, often through setbacks, so that it has
now reached a level of maturity where they are widely
used as a basis for critical design decisions: structural
and solid mechanics are examples of application areas
where CAE has revolutionized engineering. Three
decades ago, predictions by finite element models
(FEMs) were usually accompanied by experimental
results to support computational predictions. Today,
many prototypes in the automotive and civil engineer-
ing industries are exclusively built and tested with
computer-aided tools. Physical experiments are only
used in cases where FEM codes are known to be less
reliable.19
Verification and validation
Traditional fields of CAE would not be the important
tools they are today in the absence of the tremendous
efforts spent in scrutinizing the models. The totality of
these efforts, procedures, methodologies and processes
has been formalized into the field of verification &
validation (V&V). V&V is the process of assessing the
accuracy and validity of computer models and compu-
tational predictions. The subject spans from philoso-
phical issues to practical procedures on how model
reliability is quantified.
Basically, model verification deals with how the
model is implemented and the numerical accuracy of
the solution. Model validation, on the other hand, is
the process of determining how well the model repre-
sents the real world and experimental data. Roache20 in
his book on V&V tries to simplify the concepts by stat-
ing that verification deals with mathematics whereas
validation deals with physics, but, as we shall see later,
making such a clear distinction in musculoskeletal mod-
elling can be problematic.
The fundamental goal of a validation process is to
assess the computer simulation’s ability to predict cer-
tain variables of interest. Thus, the main topic of vali-
dation is the comparison of computational results with
experimental data to quantify uncertainty and errors in
the computational model. The validation process has
often been divided into three distinct parts:21
(a) comparison between computational and experi-
mental results;
(b) extrapolating the model prediction to conditions
where the model is intended to be used;
(c) determining whether the accuracy is sufficient for
the intended use.
In musculoskeletal modelling, the first issue covers
subjects such as validation experiments and model cali-
bration, which usually is the topic of publications
reporting validation studies in biomechanics. However,
the American Society of Mechanical Engineers
(ASME) guideline on validation in solid mechanics
considers all three issues to be a part of the validation
process.22 This broader definition of the validation pro-
cess emphasises that validation is also the responsibility
of the final user of the model. Given users’ different
applications of the same models, there is no definite
way of judging what level of accuracy is sufficient for a
model to be called ‘validated’. The accuracy require-
ment depends on the application and not the model
itself. Thus, when existing musculoskeletal models in
generally available modelling systems are applied to
specific problems, it is up to the user to complete the
validation process and assess whether the model is
accurate enough to be used for the intended purpose.
Figure 1 illustrates the process of validation in the
context of musculoskeletal modelling. After a model
has been proposed to address a specific question, the
process is split into modelling and experimental
branches. Figure 1 shows the close interaction required
between design of the computational model and design
of the validation experiment. At this point, it is impor-
tant to stress that the interaction does not entail chang-
ing either the model or the experiment in response to
output. In fact, the output of the model and experiment
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should not be revealed until data are ready for compar-
ison. We return to the concept of blind validation in
the section ‘Model calibration versus blind validation’.
However, the model and experiment may influence
each other in other ways. For example, an initial sensi-
tivity analysis (Figure 1) can suggest the most impor-
tant variables which must be controlled and measured
in the validation experiment. Likewise, design consid-
erations (Figure 1) may influence model design in cases
where experimental limitations prevent precise knowl-
edge of certain variables, for example, allowing the
model to handle intervals for which certain parameters
vary in the experiment or across the population.
Uncertainty quantification is the last important step in
Figure 1 before validation results are compared with
the requirements of a given model. Uncertainty infor-
mation can come from repeated measurements in the
experimental case and from sensitivity and reliability
analysis in case of model output.
It is important to realize that it is not the computa-
tional model that is validated, but rather the mathe-
matical or conceptual model behind it, which relates to
a scientific theory or hypothesis. Thus, any errors and
uncertainties caused by implementation issues, discreti-
zation errors or software bugs are usually not defined
to be part of the validation process, but belong instead
to the verification process. It is a point of discussion as
to whether this distinction between validation and veri-
fication can be made with the same precision in muscu-
loskeletal modelling. For instance, the muscle
configuration in a musculoskeletal model can be viewed
as a discretization of continuous muscles, and discreti-
zation is usually not considered to be a part of the vali-
dation process.23 However, excluding the muscle
configuration would be contrary to how validation is
usually perceived in musculoskeletal modelling.
Another case, where it is difficult to distinguish valida-
tion from verification, is checking that the code follows
the basic laws of physics. In general, we adopt an
approach that considers both these cases as validation
because they deal with the correspondence between the
model and a physical/physiological reality.
Finally, while areas such as solid mechanics or fluid
dynamics offer good opportunities to establish gold
standards for correct results through analytical models
of simple problems and accurate experimental methods,
the same is not the case for multibody musculoskeletal
modelling simply because it is very challenging to accu-
rately measure internal mechanical parameters in a liv-
ing organism.
Although a clear distinction between verification
and validation may be difficult, it is important to real-
ize that verification is a prerequisite for validation.
Verification provides the evidence that the computer
code correctly solves the underlying mathematical
model. Absence of verification creates a risk of mixing
modelling errors and errors caused by implementation
issues.
Model verification consists of two parts: the first,
sometimes called solution verification, quantifies how
the mathematical model is different from the discre-
tized model. The second part, called code verification,
investigates the actual software implementation of the
algorithm. Software bugs are found by subjecting the
algorithm to a series of benchmarking tests against
known analytical solutions.
Defining a consistent terminology
For obvious reasons, some areas of engineering have a
much more established tradition for V&V than is the
case for biomechanics. V&V has been an issue of much
debate and studies within areas such as hydrology,
nuclear reactor safety, astronautics and aeronau-
tics.21,24,25 Important general works on V&V in the
engineering literature are the review articles by
Figure 1. Illustration of the validation process in the context
of musculoskeletal modelling. The validation process begins with
the question to be explored by the model. The activities of
validation are split into an experimental and a modelling branch.
Despite dependencies between the branches, the output of
each branch should not be revealed to avoid either branch being
adjusted to match the results. When outputs are ready, the
model and experiment are quantitatively compared and, if
possible, the uncertainty of the result is quantified. This
validation result can then be compared to the requirements of a
specific application before the model is applied. If validation
results and requirements do not match, then the model may be
revised, or the experiment improved to reduce experimental
uncertainty. The activities are inspired by the ASME ‘Guide for
verification and validation in computational solid mechanics’.22
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Oberkampf and Trucano21,26 Oberkampf et al.23 and
Oberkampf and Barone,27 the book by Roache20 and
the standards and guidelines published by the American
Institute of Aeronautics and Astronautics28 and
ASME.22,29,30
A persistent problem in establishing a common view
on V&V is the confusion in terminology.24,25,31,32
Verification and validation have become the names of
two distinct processes in V&V, but in disciplines with-
out an established tradition for V&V, concepts and ter-
minology are frequently used interchangeably, and
biomechanics is no exception. Confusion also arises
since the words verification and validation clash with
the layman’s view that a validated or verified model is
also valid or true in the common sense of the word.
Nigg and Herzog33 advocate that the term model vali-
dation is dropped completely for musculoskeletal mod-
elling and model evaluation is used instead. Some
authors24,25,31 also use the term corroborated in parallel
with validation, which according to philosophers of sci-
ence is what really happens in science. Karl Popper, the
father of modern philosophy of science, argues that
postulates and theories are only scientific if they can be
disproven or falsified.34 Thus, a scientific theory/model
is never verified/validated, only corroborated.
Abandoning the word validation may be desirable, but
the term is already widely used in all parts of science
and V&V in traditional areas of engineering have
already matured so much that it is impractical to define
an independent terminology for musculoskeletal
modelling.
Biomechanics and musculoskeletal simulation
Established CAE methods are used extensively in bio-
mechanics, for instance in finite element analysis of
deformations in bones and soft tissues, and finite vol-
ume analysis for simulation of blood flow or respira-
tion. Similarly, musculoskeletal simulation relies heavily
on multibody simulation techniques originally devised
for vehicle dynamics and other technical applications.
However, life introduces significant additional com-
plexity into the models, and the fact that a method has
been accepted as reliable for a technical field does not
mean that it enjoys the same fidelity for simulation in
biomechanics. An additional challenge in biomechani-
cal modelling is that the complexity of the physical sys-
tems can only be reduced to a certain extent, leading to
more complicated models. Consequently, if validation
activities do not turn out positive, it becomes difficult
to specify why this happens and how the model can be
improved. Furthermore, there is typically a lack of
confidence in the basic inputs of the model and it is
typically much more difficult to obtain reliable experi-
mental data for living organisms to which the analysis
results can be compared.
The inferior level of maturity of biomechanical simu-
lation compared to simulation in the technical field is
likely due to these differences. In the following, we shall
therefore review the state-of-the-art of validation of
multibody musculoskeletal models and compare to the
progress of other fields of CAE that share the need for
validation but for a variety of reasons have progressed
further. Subsequently, we shall attempt to establish a
terminology that is precise enough to support a scien-
tific discourse on the subject of validation of multibody
musculoskeletal models and attempt a prediction of
initiatives that will mature the field and help realize its’
potential.
Validation concepts
There is only limited literature available which expli-
citly deals with the subject of validation within biome-
chanics. Griffin35 considered the problem of validation
a decade ago and concluded that ‘It is meaningless to
refer to a model as being a ‘‘validated model’’’ and that
‘It is more helpful to quote the limits to the applicabil-
ity and the errors of a quantitative model.’. Griffin’s
review focused on biodynamic vibration models and
did not consider V&V methodologies from other areas
of engineering. Nevertheless, many of the observations
and recommendations regarding mechanistic vibration
models are also useful in a more general sense and can
be adopted for musculoskeletal modelling. Anderson et
al.36 and Henninger et al.37 were the first to introduce
V&V methodologies in the context of biomechanics,
and these works present a few examples of the valida-
tion of FEM-based methods. Henninger et al.37 con-
cluded that a standard for validation in biomechanics is
an elusive goal given the diversity of applications and
methods. The diversity is also evident even within the
narrow scope of multibody musculoskeletal modelling,
and the majority of papers contain some aspect of vali-
dation. In the book ‘Biomechanics of the musculoskele-
tal system’ Nigg and Herzog33 identified three ways to
perform validation of musculoskeletal models: first,
direct measurements, second, indirect measurements
and third, trend measurements. Even though these
three concepts do play a role in many validation stud-
ies, there are many more aspects, which are important.
This point can be illustrated by considering the review
on model-based estimation of muscle forces by Erdemir
et al.6 Of 78 models in the review, 64 included valida-
tion, spanning a wide range of methodologies. In the
following, we give an overview of the most common
concepts and approaches in multibody musculoskeletal
modelling.
Quantitative versus qualitative validation
Almost all works in musculoskeletal modelling contain
some aspect of validation in the sense that experimental
and computational curves or values are compared,
either to justify a proposed model or provide confidence
in the conclusion of a specific research question. The
types of these comparisons vary greatly, and both quali-
tative and quantitative methods are used. Qualitative
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methods are characterized by subjective terms describ-
ing agreement between the results as for example
‘good’, ‘fair’ or ‘poor’. The qualitative approach to vali-
dation is usually taken when there is little data to sup-
port the results, or when it is necessary to compare
different physical quantities. Qualitative validation is,
for example, usually reported when time histories of
computed muscle activation are compared to electro-
myography (EMG) recordings. In such cases, qualita-
tive validation may be the only way to assess the
quality or performance of a model, and we shall return
to the topic of EMG comparisons later in this paper.
Quantitative validation is warranted in all cases
where it is possible to define an objective criterion for
the difference between the computed and experimental
quantity of interest. Such mathematical measures are
referred to as validation metrics in the context of
V&V.27 It is only by the use of validation metrics that
it is possible to take the next step and quantify the
uncertainty of the model prediction.
Stochastic versus deterministic models
The literature on V&V distinguishes between determi-
nistic and stochastic validation metrics. Deterministic
measures are single values that do not include the
uncertainty of experimental measurements or model
calculations. Stochastic validation metrics can incorpo-
rate both experimental and model uncertainties. In the
ideal case, where the probability distributions of all
parameters are known or can be estimated, it would be
possible to find the model output as a probability dis-
tribution and reject or accept the model based on some
confidence level. Such reliability methods are the sub-
ject of many V&V papers in traditional areas of engi-
neering.27,38–40 Rebba and Mahadevan39 evaluated
different statistical approaches for model validation
and concluded that the classic null point hypothesis
testing using p-values is a bad choice for model valida-
tion since it does not provide any estimate on the confi-
dence with which to reject or accept model predictions.
P-values are often misinterpreted as the probability the
null hypothesis is true.41 It can easily be seen that this
is not the case, because the p-value changes with sample
size, whereas the probability of the null hypothesis is a
constant although unknown value. Instead Rebba and
Mahadevan argued for simple statistical validation
metrics of the form r=P e\m c\ eð Þ, where m-c
is the difference between measured data and computa-
tional predictions, and e is the accuracy requirement.
The interpretation of the reliability metric r then
becomes straightforward. However, constructing such
reliability metrics is far from trivial since m and c both
have probability distributions that can be difficult to
estimate. Studies on reliability metrics in traditional
engineering are limited to the modelling of very simple
physical systems, where all parameters can be tightly
controlled or precisely measured. The full-blown relia-
bility approach to validation that combines both
uncertainties in experiment and modelling may be
desirable for musculoskeletal models, but it is probably
infeasible due to the large number of parameters and
the intra and inter-subject variability, which is unavoid-
able in biological systems and difficult to describe in
terms of probability distributions. In practice, most
studies on musculoskeletal models take an approach
that use some sort of statistical quantification of the
experimental uncertainty, while still considering the
model output as being deterministic.
Sensitivity analysis is the first step in recognizing that
the model output is not deterministic, due to uncertain-
ties in input parameters. Most sensitivity studies within
musculoskeletal modelling so far have looked at the
sensitivity of muscle force predictions to perturbations
in the muscle–tendon parameters.42–45 In all these stud-
ies, it turned out that muscle force estimates are most
sensitive to changes in the tendon slack length, with
optimal fibre length and the maximal muscle force also
being important. Other studies have indicated that the
muscle’s line of action (i.e. moment arm) is also a criti-
cal parameter46,47 both in terms of muscle force predic-
tions and the prediction of joint reaction forces.
Indirect versus direct validation
Direct validation is the case where it is possible to
directly compare a model output of interest with an
experimental measurement of the same quantity. Joint
reaction force is an example of a quantity, which is nor-
mally impossible to measure in-vivo, but can be mea-
sured in special circumstances, where patients have
been fitted with instrumented joint replacements.48–51
Such select cases therefore offer a direct validation of
musculoskeletal models.
Although examples of direct validation of musculos-
keletal models exist, the opportunities remain rare.
Models are built with the intention of predicting a spe-
cific scenario or explaining a phenomenon, which is dif-
ficult or costly to investigate empirically, or the model
is used as a scientific tool upon which it is possible to
perform experiments which for ethical or safety reasons
cannot involve humans. Thus, validation studies of
such models are also inherently difficult, costly and
ethically problematic to perform. Since such scenarios
are common in musculoskeletal modelling, many stud-
ies focus their validation efforts on other variables in
the model that are easier to measure experimentally.
The motivation for this approach is that any confi-
dence in a model’s ability to predict measureable vari-
ables may reflect on the confidence of the variable of
interest that cannot be measured. A common type of
such indirect validation is comparison of EMG mea-
surements with predicted muscle forces to infer confi-
dence in estimation of joint compressive forces.52,53
Even though indirect validation may provide some
evidence that something in the model is behaving as
expected, it does not guarantee that the model can cor-
rectly predict the actual quantity of interest. This means
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that, even though indirect validation is both quantita-
tive and objective, it will eventually result in a subjec-
tive and qualitative assessment, when the confidence in
the model’s performance is transferred from the indi-
rect measurements to the actual quantity of interest.
Trend versus absolute validation
Should a model be trusted just because it happens to
pass the requirements in the validation process? This
question is important because a model may be able to
make correct predictions while still being wrong at the
conceptual level. In other words, it may be correct but
for the wrong reasons. This is particularly a danger
when the model has been calibrated to match experi-
mental data. What is important then is not the absolute
difference between model and experiment, but instead
how the underlying variables interact. Only if the
underlying conceptual model is physically sound will it
be possible to use models without performing valida-
tion experiments to confirm results. The investigation
of the correctness of variable interaction is called trend
validation, and its importance was emphasized by Nigg
and Herzog33 more than a decade ago. Successful trend
validation is an important prerequisite if models and
simulation are to be used for the so-called ‘what–if’ sce-
narios. If we make an intervention by changing a cer-
tain parameter, what will happen to the output of
interest? Such a question could be very relevant if we
want to use a musculoskeletal model for predicting the
outcome after a surgical intervention. To answer these
kinds of questions, the model parameters must interact
correctly with each other.
Model calibration versus blind validation
The differentiation between blind and non-blind valida-
tion comes from the idea that validation should be per-
formed against independent data that was not used to
construct the model. Knowing the results in advance
poses the risk that validation studies degrade into sim-
ple calibration of the model. As stressed in a number of
publications on V&V in other areas of engineer-
ing,21,24,54 calibration and validation are two different
tasks. Calibration is about finding the best parameter
values for the model in order to fit measured data,
whereas validation is assessing how well the model can
predict experimental data. Calibration is a natural part
of constructing a new model, but the data used for cali-
bration cannot afterwards be used to validate the
model.
Real blind validation is rare in musculoskeletal mod-
elling, since both modeller and experimentalist are
often the same person or group of people. It is there-
fore commendable to be critical about validation
results when the analyst has seen the data in advance.
Oberkampf and Trucano21 state that ‘Knowing the
‘‘correct answer’’ before hand is extremely seductive,
even to a saint’.
Even though blind validation is rare, recent attempts
have been made to introduce this methodology in
musculoskeletal modelling. The ‘Grand Challenge
Competition to Predict in vivo Knee Loads’ is a project
run at the ASME Summer Bioengineering conferences.
Starting in 2010 and planned to last until 2016, it pro-
vides a series of comprehensive experimental data sets
to allow the musculoskeletal modelling community to
participate in an annual competition to predict knee
compressive forces during different kinds of gait. The
in-vivo measured compressive forces are only disclosed
to the contestants at the conference when the simulated
results had been published.55 In addition to being an
example of true blind validation, the competition is
also evolving into a database of freely available valida-
tion benchmarks for simulating knee models.
Validation frameworks and benchmarks
When systems increase in scale and complexity, it
becomes increasingly difficult to do true validation on
the top-level systems. An example from a field in
which this problem has been evident for a long time is
simulation of catastrophic failures of complex high-
consequence systems such as airplanes, nuclear power
plants and nuclear storage facilities. These are simula-
tions, which cannot be physically tested. However, it is
still necessary to gain confidence in the predictions of
the top-level model. The engineering approach to this
dilemma was to divide the problem into a hierarchy of
parts and sub-systems, which could be handled and
validated, individually.
Validation hierarchy
Babuška et al.56 illustrates the validation hierarchy with
respect to FEM methods with a commercial aircraft. On
the top level is the full aircraft model, which cannot be
validated in full scale. On the tiers below are models of
the major components, such as wings and fuselage
together with their corresponding accreditation tests. On
next lowest tiers are models of the minor components
and structural elements and on the lowest level are mate-
rial models and the corresponding material testing.
The concept of a validation hierarchy is also relevant
for musculoskeletal modelling, when validation experi-
ments on the top-level model are not possible. There are
two areas in which a hierarchical approach to validation
may be especially useful in musculoskeletal modelling.
The first is those cases where validation experiments
cannot be performed for ethical reasons. This could, for
example, involve computational models to investigate
injury mechanics or trauma. The second case is patient-
specific models, where all models are different to a lesser
or greater extent and each of the models is restricted to
the prediction of some specific quantity or outcome
without having to measure it directly.
Oberkampf and Trucano21 in their work on valida-
tion benchmarks, pointed out that construction of a
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validation hierarchy is useful for several key reasons.
First, it captures ‘a large range of complexities in sys-
tems, physics, material and geometries’, and opens new
possibilities in validation experiments, which could not
be done on the top-level model. For musculoskeletal
modelling, this entails a need to rethink what constitu-
tes validation experiments. Subsystems and submodels
may be validated in-vivo in animal experiments, in-
vitro with cadaver specimens or totally different kinds
of experiments. Second, Oberkampf and Trucano21
pointed out that the validation hierarchy requires many
different experts to work together to construct the hier-
archy of validation studies, which may uncover interac-
tions between subsystems that were not previously
taken into account. Finally, it allows the results of vali-
dation on one level of the hierarchy to be related in
terms accuracy to levels above and below.
The latter point is the more challenging.
Musculoskeletal models, especially those included in
generally available software systems, are often com-
prised of a number of subsystems and submodels and
rely on particular methods, many of which have previ-
ously been published in the scientific literature. These
are, for example, body part models, muscle configura-
tions, joint models and methodologies such as different
scaling procedures and muscle recruitment criteria. The
point that there might also be a considerable publica-
tion bias when reporting the performance of new mod-
els and methods should not be ignored. The examples
selected for publication are naturally those that per-
form the best. When the same methods/models are later
included in musculoskeletal software packages, the con-
text and assumptions under which they were originally
validated may be different from the context for which
the users decide to apply the models.
Gathering the relevant information for a validation
hierarchy and relating the data in a sensible fashion is
not trivial. Scientific papers presenting validation results
are rarely published with hierarchical validation in mind,
and the subsystem of the musculoskeletal system and
their interactions are not as simple to characterize as tra-
ditional engineering constructs. They are frequently sub-
ject to the deficiencies outlined in the previous
paragraphs and it may be difficult to extract the neces-
sary quantitative information on model accuracy that
can be related to other levels of the validation hierarchy.
Ultimately, this means that submodels cannot always
contribute directly to an assessment of the accuracy and
shortcomings of the top-level model. Despite the clear
limitation associated with applying the validation hierar-
chy outside the scope of traditional areas of engineering,
it does provide some benefits and opportunities for mus-
culoskeletal modelling which are emphasized in the sec-
tion ‘Validation hierarchy for musculoskeletal models’.
Validation benchmarks
The previous paragraph listed a number of reasons for
scepticism towards model performance reported in the
scientific literature. However, models may also improve
after they are first published. We must keep in mind
that models/methods are rarely one-shot developments,
but evolve in an iterative process. Thus, the validation
results or performance reported in the first publications
on a model may be very different from how the model
performs later. Biomechanists may therefore be reluc-
tant to publish validation studies that objectively state
the accuracy of a model, since such work remains
locked in the scientific literature, while the model may
later improve. This problem is especially relevant when
working with musculoskeletal modelling packages,
which tend to produce major updates every one or two
years. By the time a validation study has been per-
formed, analysed and published, a new version with
supposedly superior qualities will have been released.
The consequence is that the majority of studies that can
be found in the scientific literature are based on older
modelling packages than what is currently ‘state-of-the-
art’. Although modelling software usually improves
with each new release, the opposite can also be the case.
Models are so complex that there is no way of knowing
this for sure by just studying the release log.
Commercial code companies in traditional areas of
engineering have faced similar challenges with the
release of new versions. The solution has been to pro-
vide users with benchmark examples that can be run
with the previous and new versions and results can doc-
ument the accuracy and reliability of the physical mod-
els and codes. Oberkampf and Trucano21 surveyed
leading CAE software for solid mechanics and found
several CAE software products like ANSYS58 and
ABAQUS57 that provide well-documented verification
benchmarks to illustrate the code performance and engi-
neering accuracy. Establishment of similar verification
benchmarks for musculoskeletal modelling software is
an obvious opportunity, albeit with the difference that
there are no simple examples in musculoskeletal model-
ling for which analytical solutions exist for comparison.
There have been a few efforts to provide something
equivalent to V&V benchmarks for musculoskeletal
modelling. One of the most noteworthy is the
OrthoLoad project,59 which provides a database of
measurements from instrumented joint implants per-
orming various daily activities. The database does not
contain true validation benchmarks but instead snap-
shots of valuable empirical data in the sense that they
are obtained from particular individuals with particular
impairments performing particular tasks. To the extent
the test subjects and the selected activities can be mod-
elled in software, they provide an excellent opportunity
for a top-level validation of simulated joint reaction
forces. Currently the database is lacking the necessary
high-quality measurements documenting anthropome-
try, kinematics and external forces, however, the
OrthoLoad homepage59 states the ambition to add
them: ‘In the future additional information like ground
reaction forces and gait data will be added’. If done
carefully, the database could become a very important
88 Proc IMechE Part H: J Engineering in Medicine 226(2)
source for validation benchmarks for musculoskeletal
modelling. Another project with a similar ambition for
musculoskeletal modelling is the ‘Grand Challenge
Competition to Predict in vivo Knee Loads’.55
The data sets provided by both of these projects
belong to the top level of the validation hierarchy dis-
cussed earlier. Top-level data carry the risk that experi-
mental and computational results agree, even though a
submodel is still incorrect. This can be caused by the
top-level model being insensitive to the incorrect sub-
model, or by several submodel errors accidentally can-
celling one another. The former case is benevolent on
the top level, whereas the risk of the second case
diminishes with the provision of more data sets for top-
level validation and with the execution of trend valida-
tion as discussed in the section ‘Trend versus absolute
validation’. Therefore, large databases of top-level vali-
dation benchmarks will be valuable.
It is worth noting that all models are essentially
based on assumptions and approximations, for
instance, the assumption of rigidity of the bones, and if
decomposed sufficiently into subsystems, they will
arrive at a point where these assumptions are obviously
wrong.
Opportunities for musculoskeletal model
validation
It is clear from the previous section that a standard pro-
cedure for validation similar to that advocated in solid
mechanics may be an elusive goal in musculoskeletal
modelling, given the large variability in biological sys-
tems, the difficulties in measuring output variables and
the diversity of applications. It has been claimed that
validation is inherently impossible, since scientific mod-
els or hypotheses can only be falsified but never proven
valid.60,61 Although this is a widely accepted point-of-
view in philosophy of science, the applicability of engi-
neering models is undisputed. We can therefore con-
clude that many physical models rely on the confidence
within a limited domain that comes from repeated
unsuccessful attempts at falsification. It seems obvious
that the same principle may apply to the dissemination
of musculoskeletal models into practical use.
Even though it might not yet be possible to establish
standards or even guidelines for validation of muscu-
loskeletal models, there are a number of practical
approaches that may advance the field of musculoske-
letal modelling.
Stronger focus on trend validation
The investigations of the so-called ‘what–if’ scenarios
are often mentioned as one of the most promising uses
of musculoskeletal models.6 However, as already indi-
cated, this requires that the model parameters interact
with each other in the correct manner, which can be
tested using a trend validation. A musculoskeletal
model that results in the correct trends but at inaccu-
rate absolute values can still be useful in many cases.
This situation is likely to occur because musculoskeletal
models have many uncertainties in the input para-
meters. Despite the importance of predicting the correct
trends, systematic trend validations of musculoskeletal
models are scarce in the literature. We recommend that,
in the hierarchy of validation results, emphasis should
be placed upon trend results. This requires carefully
planned validation experiments in which one or more
parameters can be changed systematically, while moni-
toring an output measure as a function of those para-
meters. Changing the same parameters in the
simulation enables comparison of trends as well as the
absolute values. An example of a trend validation
experiment is given by Olesen et al.62 in which seating
posture is systematically changed while measuring the
shear forces between the body and seat and subse-
quently comparing with a computer simulation model.
Better comparison of EMG with data
In the earlier mentioned review by Erdemir et al.,6 43
out of 68 attempts to validate multibody musculoskele-
tal models relied on EMG comparisons. The inability
to measure muscle forces directly leaves the researcher
with the option of using EMG measurement to obtain
information about the active state of a muscle and com-
paring it with a simulated active state. Unfortunately,
the active state computed in musculoskeletal modelling
software is not a direct simulation of EMG for dynamic
cases. Therefore, many authors compare only the tim-
ing of onset and offset of muscles between the model
and the experiment, thus failing to take advantage of
the richness of the EMG signal.63–66
Praagman et al.67 used the near infrared spectro-
scopy technique to show proportionality between meta-
bolism and EMG in single muscles for isometric cases.
It is not known whether this finding also applies to
dynamic muscle contraction, but it sparks the idea of
developing a direct EMG simulation, possibly based on
metabolism models. Many of the necessary parameters,
such as contraction velocity and fibre length, are readily
available in the musculoskeletal model, but the problem
of predicting a multi-dimensional EMG signal from a
single-dimensional computed muscle active state must
be solved.
Even if development of an EMG simulation were
successful, experimentalists should bear in mind that
EMG is not simple to record reliably. The recorded sig-
nal from surface electrodes is subject to significant
cross-talk and depends on the position of the EMG
electrode both over the muscle and in relation to the
neuromuscular junction or nerve innervation zone.
EMG electrodes placed over the innervation zones
record remarkably lower activity, and if innervation
zones move under the electrodes, as it happens in
dynamic conditions, it may be misinterpreted as
changes of muscle activation level.68 These vary
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between muscles and for the same muscle between dif-
ferent subjects. Recording EMG with multiple electro-
des over the same muscle may, therefore, be the only
way to obtain reliable information. Given the limita-
tion of EMG measurements in validation, the actual
role of traditional EMG measurements may be limited
to rejecting models which produce a clearly wrong
result.
Development of quantitative validation metrics
We have emphasized that for validation to be useful, it
must be based as much as possible on quantitative mea-
sures. Quantitative validation is warranted in all the
cases where it is possible to define validation metrics
(i.e. a mathematical measure of the difference between
computational and experimental results).
Single values are typically compared in terms of
their relative error, and standard statistical methods
are well suited for these tasks. However, the same
methods are less useful when the computational output
is not a single value but is instead a complex transient
response. As an example, consider two similar curves
shifted slightly along the abscissa. If the curves change
rapidly, the relative difference can become very large.
The comparison becomes sensitive to inaccuracies on
the abscissa, and the magnitude of the quantity itself.
Thus, the relative error (or some summation of it) is a
poor indicator of model accuracy, and it is likely that
the measure will correlate poorly with the subjective
impression of experts simply looking at the graphs.
As previously mentioned, other areas of engineering
have faced similar challenges. Schwer69 studied quanti-
tative means to compare complex waveforms with the
goal of minimizing subjectivity, while still maintaining
correlation with expert opinions. Curve comparison
metrics divide the error into two parts: a magnitude
error M, which is insensitive to inaccuracies on the
abscissa; and a phase error P that does not depend on
the amplitude of the curve. The magnitude error and
phase error are then combined to produce a single value
that represents the difference between curves. Consult
Schwer69 and Lund et al.70 for a detailed description of
the metrics. Schwer69 showed that this kind of valida-
tion metric was able to mimic how 11 experts evaluated
a model of seismic wave propagation. Please note that
the practical validation against EMG onset and offset
in this framework can be interpreted as putting empha-
sis only on the phase error.
We believe that curve comparison metrics hold a
potential to further quantitative methods in musculos-
keletal model validation and should be explored in
future research.
Validation hierarchy for musculoskeletal models
Development of a carefully planned validation hierar-
chy for musculoskeletal models may significantly
enhance the state-of-the-art in the field by allowing
modellers to initiate coordinated V&V on lower levels
to facilitate higher level validation.
Figure 2 shows a possible validation hierarchy
scheme for musculoskeletal models. The Hill model,
often used in musculoskeletal modelling, is an example
of the low-level submodels. Validation experiments for
submodels, methods and model structures can be per-
formed separately and the quantitative performance
may serve as input for validation on systems at the level
above. Even though this is not always possible, the vali-
dation hierarchy will still serve as a valuable overview
and documentation of validation activities on all levels
of the model. Thus, it allows others to recreate the vali-
dation studies, and makes the model performance and
assumptions transparent to the end user.
Top-level validation is likely infeasible without quan-
titative validation of lower levels. In the following, we
therefore mention some obvious opportunities for low-
level validation activities.
Mechanical models. Mechanical models of musculoskele-
tal systems are subject to the laws of mechanics. This
offers obvious opportunities for both verification and
validation of models based on established equilibrium
principles in forces, energy or momentum. The advan-
tage of these approaches is that a single error in a very
complicated mechanical system will often create an
overall imbalance that can be detected like a checksum.
An example of a typical error detected by energy
imbalance is work unintentionally performed by reaction
forces between mechanical elements. This can be detected
as a difference between the work performed by the exter-
nal forces and the work performed by the muscles. This
may happen in musculoskeletal models when measured
joint kinematics are imposed on the model, for instance
measured knee kinematics in two or three dimensions,71
and reaction forces are introduced in the same directions.
Another case is muscles wrapping over bones, where
the work of the contact forces against the moving bone
may be difficult to compute correctly. Errors in this
type of model can also be detected as a difference
between the work of internal and external forces.
Behaviour of physiological models. Detailed musculoskele-
tal models literally contain thousands of parameters, all
of which may have complex influences on the results.
Checks for non-physiological behaviours of the model
may help identify problems in the model and localize
the root of the observed errors. Examples are checks
for symmetric results when symmetric models are sub-
jected to symmetric loads, or checks of the model-
predicted strength of joints against experimental data.
Experimentally investigated joint strengths are subject
to significant inter-person variation, but the joint
strengths as a function of joint angles of, for instance,
knee extension or elbow flexion, exhibit some similari-
ties over subjects even though the absolute values may
vary, cf. the aforementioned discussion on the value of
trend validation.
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A validation framework for musculoskeletal models
In engineering simulation, leading companies, such as
ANSYS58 and Simulia57 and independent organiza-
tions, such as National Agency for Finite Element
Methods and Standards72 have established verification
benchmarks for finite element products. This is done in
the realization that published V&V results are snap-
shots of the situation at a specific time, after which
models and software continue to evolve.
The development of musculoskeletal models is likely
an open-ended activity in which model and algorithm
improvements will continue for the foreseeable future,
and this creates a similar need for V&V benchmarks or
frameworks that evolve with the methods and allow for
comparison not only between simulated and experimen-
tal results but also between different versions of soft-
ware and models.
A validation framework will allow a user to
obtain data for the model validity on a number of
cases. It then becomes the obligation of the user
to interpret the information and evaluate the credibil-
ity of the model for a prospective simulation
(Figure 1).
Such a validation framework would provide users
with the documentation needed to evaluate the perfor-
mance of the models without having to rely on results
in outdated publications. Implementation of a growing
number of validation benchmarks and experimental
studies into the framework would not only ensure that
these studies and data sets continue to be available for
users to judge model credibility, but it would also serve
as building blocks for a growing validation hierarchy.
There are two main requirements for this vision to
become reality. First, the validation framework would
need to be maintained by the communities or companies
behind the musculoskeletal modelling packages. Second,
researchers, who perform validation studies, have to
make the data publicly available for others to re-use.
These two requirements call for careful design of software
to collect and manage the data and allow for interaction
with users, submitting data to enrich the framework.
Conclusions
We have focused on how improving the practice and
methodology of validation can help increase the
Figure 2. Validation hierarchy for musculoskeletal models. The figure shows some examples of methods and submodels that can
be validated separately.
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credibility of musculoskeletal models. The following
points sum up the key features and concepts behind
model V&V experiments.
Essential general findings on validation
1. Validation is an open-ended process tightly linked
with the evolution of models and algorithms, and
validation experiments are specific to a certain use
of the model. It is, therefore, not relevant to refer
to a model as being ‘validated’ in general.
2. Validation can only be carried out with respect to
certain applications based on which a user judges
whether the model is adequate for a specific task.
3. Model development and validation experiments
are closely linked. The model sensitivities to
changes in the input parameters decide the para-
meters to control or vary in the validation experi-
ment and the precision with which they need to be
measured. Therefore, methods for quantifying
uncertainties in musculoskeletal models need to be
developed.
4. Validation experiments are characterized by partic-
ular requirements for measurement and documen-
tation of all important parameters and their
uncertainty. Thus, not all experiments qualify as
validation experiments.
5. Quantitative validation metrics are encouraged in
all cases where experimental and simulation results
are compared. Further research on these metrics
for use with musculoskeletal model validation is
needed.
6. Blind validation is essential to avoid bias in the
results. Validation against experimental results that
are not revealed until the computational results are
ready is, therefore, the ideal situation.
7. Models and algorithms should be tested against
experimental measurements over a wide range of
applications.
Topics for further study in order to improve the
validation of musculoskeletal models
1. Establishment of a consistent terminology on mus-
culoskeletal modelling V&V corresponding with
what has been adopted in traditional areas of
CAE.
2. Establishment of validation hierarchies through
which models can be validated at increasing levels
of complexity.
3. Development of validation benchmarks open for
third-party scrutiny, and documented sufficiently
to allow recreation of the validation experiments
with other assumptions, parameters or algorithms.
4. Specification of validation experiment require-
ments. On the lower tiers of the validation hierar-
chy, there is a possibility to use other approaches
than in-vivo experiments, for example cadaver
studies, checks against the laws of physics or ani-
mal experiments.
Musculoskeletal modelling is undergoing an exciting
change from the realms of research into real applica-
tions. The potential benefit to medical treatments,
product design, health and safety in the workplace and
many other applications is tremendous, but it must also
be realized that errors, uncertainties and unqualified
use may have serious consequences. This situation is
similar to the evolution of other CAE domains and
similarly serious efforts in model validation will be nec-
essary for musculoskeletal models.
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